The difference type and disease severity in a family with spinal muscular atrophy (SMA)

被引:0
|
作者
Harahap, I. S. K. [1 ]
Thursina, C. [2 ]
Sadewa, A. H. [3 ]
Hapsara, S. [4 ]
机构
[1] Univ Gadjah Mada, Neuromucular Div, Dept Neurol, Fac Med, Yogyakarta, Indonesia
[2] Univ Gadjah Mada, Neuropediat Div, Dept Neurol, Fac Med, Yogyakarta, Indonesia
[3] Univ Gadjah Mada, Biochem, Fac Med, Yogyakarta, Indonesia
[4] Univ Gadjah Mada, Dept Pediat, Fac Med, Yogyakarta, Indonesia
关键词
D O I
10.1016/j.jns.2017.08.796
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
768
引用
收藏
页码:279 / 279
页数:1
相关论文
共 50 条
  • [31] Respiratory management of children with spinal muscular atrophy (SMA)
    Fauroux, B.
    Griffon, L.
    Amaddeo, A.
    Stremler, N.
    Mazenq, J.
    Khirani, S.
    Baravalle-Einaudi, M.
    ARCHIVES DE PEDIATRIE, 2020, 27 (07): : 29 - 34
  • [32] Cost of illness of spinal muscular atrophy (SMA) in Italy
    Marcellusi, Andrea
    Bini, Chiara
    Casiraghi, Jacopo
    D'Ambrosio, Francesco
    Rotundo, Maria A.
    Pallara, Anita
    Menninii, Francesco S.
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2019, 2019
  • [33] Constitutive role of mitochondria in Spinal Muscular Atrophy (SMA)
    Acsadi, Gyula
    Li, Xingli
    Hutterman, Maik
    Dombkowski, Alan
    Parker, Graham
    NEUROLOGY, 2008, 70 (11) : A136 - A137
  • [34] The international spinal muscular atrophy (SMA) registry: longitudinal collection and refinement of outcome measures for spinal muscular atrophy
    Scoto, M.
    Muntoni, F.
    Hall, S.
    Eaton, S.
    Rashid, A.
    Avendano, J.
    Samsuddin, S.
    Balashkina, J.
    Finkel, R.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S198 - S198
  • [35] Respiratory Issues in patients with Spinal Muscular Atrophy (SMA) type 1, Treated with Disease-Modifying Therapy
    Gaboli, Mirella
    Lopez-Lobato, Mercedes
    Madruga-Garrido, Marcos
    Borrero-Rodriguez, Macarena
    Palomo-Pavon, Alejandro
    Escudero-Avila, Rocio
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [36] Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1
    Fitzgerald, Dominic A.
    Doumit, Michael
    Abel, Francois
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 28 : 11 - 17
  • [37] Language development in spinal muscular atrophy (SMA) type 1 children treated with nusinersen
    Brusa, C.
    Scoto, M.
    Manzur, A.
    Main, M.
    Muntoni, F.
    Vargha-Khadem, F.
    Baranello, G.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S187 - S187
  • [38] Nusinersen Experience in Individuals with Spinal Muscular Atrophy (SMA) Type III: A Case Series
    Chiriboga, C.
    Kirschner, J.
    Swoboda, K.
    Mercuri, E.
    Darras, B.
    Foster, R.
    Bhan, I
    Farwell, W.
    ANNALS OF NEUROLOGY, 2018, 84 : S351 - S351
  • [39] Evaluating the respiratory health of children with spinal muscular atrophy (SMA) type 1 on Nusinersen
    Grime, Chris
    Edel, Lisa
    Robinson, Victoria
    Rendel, Gareth
    Abel, Francois
    Chan, Elaine
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [40] Burden of illness of spinal muscular atrophy type 1 (SMA1): an update
    Droege, M.
    Dabbous, O.
    Arjunji, R.
    Gauthier-Loiselle, M.
    Cloutier, M.
    Sproule, D.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S70 - S70